Quantitative analysis of microbubble-enhanced ultrasound for diagnosis of sentinel lymph node metastasis of uterine cervical cancer and uterine body cancer

Quantitative analysis of microbubble-enhanced ultrasound for diagnosis of sentinel lymph node metastasis of uterine cervical cancer and uterine body cancer - Diagnosis of sentinel lymph node metastasis using microbubble-enhanced ultrasound of uterine cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021721

Enrollment

100

Registered

2016-04-01

Start date

2016-04-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine cervical cancer, uterine body cancer

Interventions

After detection of sentinel lymph node, we inject SONAZOID for injection by intravenous and get the enhanced ultrasound imaging. Usual dosage for an adult is 0.015mL/kg body weight in a single admini

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Stage 1 and 2A of uterine cervical cancer or Stage 1 and 2 of uterine body cancer. patients scheduled operation and examination of sentinel lymph node. Description and consent.

Exclusion criteria

Exclusion criteria: Right-left shunt of heart or lung Egg allergy Pregnant woman Hypersensitivity of sonazoid Severe heart disease or lung disease Unstable psychological symptom

Design outcomes

Primary

Measure	Time frame
quantitative analysis of contrast-enhanced ultrasound imaging for sentinel lymph node	—

Countries

Japan

Contacts

Public ContactAsami Toki

Tohoku University Hospital Department of Obstetrics and Gynecology

asa_tannpopo_pon@yahoo.co.jp022-717-7254

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026